The Direct Involvement of SirT1 in Insulin-induced Insulin Receptor Substrate-2 Tyrosine Phosphorylation

Jiandi Zhang

Journal of Biological Chemistry · 2007 · 168 citations · 37 references

DOIFull text

Open access

Concepts

Abstract

NAD+-dependent Sir2 family deacetylases and insulin signaling pathway are both conserved across species to regulate aging process. The interplay between these two genetic programs is investigated in this study. Protein deacetylase activity of SirT1, the mammalian homologue of Sir2, was suppressed through either nicotinamide treatment or RNA interference in several cell lines, and these cells displayed impaired insulin responses. Suppression of SirT1 activity also selectively inhibited insulin-induced tyrosine phosphorylation of insulin receptor substrate 2 (IRS-2), whereas it had minimal effect on that of IRS-1. Further analyses showed that both IRS-1 and IRS-2 interacted with SirT1, and the acetylation level of IRS-2 was down-regulated by insulin treatment. Inhibition of SirT1 activity prevented deacetylation and insulin-induced tyrosine phosphorylation of IRS-2. Mutations of four lysine residues to alanine in IRS-2 protein, on the other hand, led to its reduced basal level acetylation and insulin-induced tyrosine phosphorylation. These results suggest a possible regulatory effect of SirT1 on insulin-induced tyrosine phosphorylation of IRS-2, a vital step in insulin signaling pathway, through deacetylation of IRS-2 protein. More importantly, this study may imply a pathway through which Sir2 family protein deacetylases and insulin signaling pathway jointly regulate various metabolic processes, including aging and diabetes. NAD+-dependent Sir2 family deacetylases and insulin signaling pathway are both conserved across species to regulate aging process. The interplay between these two genetic programs is investigated in this study. Protein deacetylase activity of SirT1, the mammalian homologue of Sir2, was suppressed through either nicotinamide treatment or RNA interference in several cell lines, and these cells displayed impaired insulin responses. Suppression of SirT1 activity also selectively inhibited insulin-induced tyrosine phosphorylation of insulin receptor substrate 2 (IRS-2), whereas it had minimal effect on that of IRS-1. Further analyses showed that both IRS-1 and IRS-2 interacted with SirT1, and the acetylation level of IRS-2 was down-regulated by insulin treatment. Inhibition of SirT1 activity prevented deacetylation and insulin-induced tyrosine phosphorylation of IRS-2. Mutations of four lysine residues to alanine in IRS-2 protein, on the other hand, led to its reduced basal level acetylation and insulin-induced tyrosine phosphorylation. These results suggest a possible regulatory effect of SirT1 on insulin-induced tyrosine phosphorylation of IRS-2, a vital step in insulin signaling pathway, through deacetylation of IRS-2 protein. More importantly, this study may imply a pathway through which Sir2 family protein deacetylases and insulin signaling pathway jointly regulate various metabolic processes, including aging and diabetes. Calorie restriction, the only physiological method known so far to extend lifespan in animals ranging from Caenorhabditis elegans to mammals, is associated with global metabolic changes, including reduced insulin level, increased gluconeogenesis, and reduced lipid metabolism. The identification of Sir2 as the mediator of calorie restriction on lifespan regulation is a major breakthrough in understanding the molecular mechanism underlying the aging process (1Fontana L. Meyer T.E. Klein S. Holloszy J.O. Proc. Natl. Acad. Sci. U. S. A. 2004; 101: 6659-6663Crossref PubMed Scopus (731) Google Scholar, 2Blander G. Guarente L. Annu. Rev. Biochem. 2004; 73: 417-435Crossref PubMed Scopus (1313) Google Scholar). Sir2 and its mammalian counterpart, SirT1, belong to a family of NAD+-dependent protein deacetylases. Sir2 is actively involved in lifespan regulation in C. elegans, yeast, and Drosophila. Disruption of Sir2 gene leads to a reduced lifespan, whereas overexpression of Sir2 leads to significant lifespan extension in these species (2Blander G. Guarente L. Annu. Rev. Biochem. 2004; 73: 417-435Crossref PubMed Scopus (1313) Google Scholar). In the mammalian system, SirT1 has been involved in multiple metabolic processes including glucose homeostasis (3Rodgers J.T. Lerin C. Haas W. Gygi S.P. Spiegelman B.M. Puigserver P. Nature. 2005; 434: 113-118Crossref PubMed Scopus (2610) Google Scholar), insulin secretion (4Bordone L. Motta M.C. Picard F. Robinson A. Jhala U.S. Apfeld J. McDonagh T. Lemieux M. McBurney M. Szilvasi A. Easlon E.J. Lin S.J. Guarente L. PLoS Biol. 2006; 4: e31Crossref PubMed Scopus (625) Google Scholar, 5Moynihan K.A. Grimm A.A. Plueger M.M. Bernal-Mizrachi E. Ford E. Cras-Meneur C. Permutt M.A. Imai S. Cell Metab. 2005; 2: 105-117Abstract Full Text Full Text PDF PubMed Scopus (546) Google Scholar), and lipid mobilization (6Picard F. Kurtev M. Chung N. Topark-Ngarm A. Senawong T. Oliveira R.M. Leid M. McBurney M.W. Guarente L. Nature. 2004; 429: 771-776Crossref PubMed Scopus (1679) Google Scholar). However, its role in lifespan regulation remains ambiguous. Insulin signaling pathway is also actively involved in the aging process (7Tatar M. Bartke A. Antebi A. Science. 2003; 299: 1346-1351Crossref PubMed Scopus (1048) Google Scholar). As a critical component of overall energy homeostasis, insulin signaling pathway has been well studied, and the key steps have been characterized (8Kahn C.R. Vicent D. Doria A. Annu. Rev. Med. 1996; 47: 509-531Crossref PubMed Scopus (207) Google Scholar). Insulin signaling pathway is initiated by auto tyrosine phosphorylation of insulin receptor upon insulin binding, and subsequently tyrosine phosphorylations of several key adaptor proteins including insulin receptor substrate 1 (IRS-1) 2The abbreviations used are: IRS-1, insulin receptor (IR) substrate 1; RNAi, RNA interference; SC cells, stable control cells; SS cells, stable SirT1 cells; Luc, luciferase; MAPK, mitogen-activated protein kinase. and IRS-2. The phosphorylated IRS proteins further transmit insulin signaling to downstream events, mainly through two kinase cascades, the mitogen-activated protein kinase cascade (MAPK) and phosphatidylinositol 3-kinase-Akt cascade. Genetic studies using C. elegans as a model system demonstrate a tight connection between insulin signaling pathway and aging. Mutations at several key components of insulin signaling pathway, including daf-2 (Insulin receptor), Age-1 (phosphatidylinositol 3-kinase), and daf-16 (Foxo proteins), all significantly extend the lifespan of C. elegans (7Tatar M. Bartke A. Antebi A. Science. 2003; 299: 1346-1351Crossref PubMed Scopus (1048) Google Scholar). Likewise, inactivation of insulin receptor in adipose tissue leads to extended lifespan in mice (9Bluher M. Kahn B.B. Kahn C.R. Science. 2003; 299: 572-574Crossref PubMed Scopus (1071) Google Scholar), and deletion of Klotho, a protein potently inactivating insulin receptor activity in cell culture studies, accelerates aging process in mutant mice (10Kurosu H. Yamamoto M. Clark J.D. Pastor J.V. Nandi A. Gurnani P. McGuinness O.P. Chikuda H. Yamaguchi M. Kawaguchi H. Shimomura I. Takayama Y. Herz J. Kahn C.R. Rosenblatt K.P. Kuro-o M. Science. 2005; 309: 1829-1833Crossref PubMed Scopus (1411) Google Scholar). In this laboratory resveratrol, a chemical compound known to extend lifespan in several species including C. elegans, yeast, and Drosophila, has also been demonstrated to inhibit insulin signaling pathway in cell culture studies (11Zhang J. Biochem. J. 2006; 397: 519-527Crossref PubMed Scopus (110) Google Scholar). These observations support a vital role of insulin signaling pathway in aging process. The associations of both the insulin signaling pathway and the Sir2 family protein deacetylases with the aging process raise an important question; do these two pathways independently or jointly regulate aging process? In other words, is there any direct association between these two pathways? This question is explored in this study, and the results provide direct evidence supporting a novel role of SirT1 in regulating insulin-signaling pathway in mammalian cells. General Reagents—Various cell culture reagents, including Dulbecco's modified Eagle's medium, M199 medium, penicillin/streptomycin, and fetal bovine serum were obtained from Fisher. Insulin was obtained from Sigma. Antibodies against p44/42 MAPK, phospho-AKT (serine 473 and threonine 308), AKT, and acetylated lysine polyclonal antibodies were obtained from Cell Signaling Technology (Beverly, MA). Monoclone FLAG antibody (M2) and phospho-p44/42 MAPK monoclonal antibody were obtained from Sigma. Anti-acetyl lysine 4G12 and anti-phosphotyrosine 4G10 antibodies were obtained from Millipore (Lake Placid, NY). Antibodies against insulin receptor β, retinoblastoma, were obtained from BD Biosciences. Antibodies against SirT1, cAMP-responsive element-binding protein-1, IRS-1, IRS-2, normal mouse IgG, normal rabbit IgG, and protein A/G plus beads were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Cell Culture—H4IIE, HEK293 cells, were maintained in Dulbecco's modified Eagle's medium supplemented with 5% fetal bovine serum. Rat primary hepatocytes were isolated as described previously (11Zhang J. Biochem. J. 2006; 397: 519-527Crossref PubMed Scopus (110) Google Scholar) and set up in M199 medium supplemented with 100 100 insulin were M199 medium supplemented with 100 further Cell cells were at and in Dulbecco's modified Eagle's medium supplemented with 5% fetal bovine serum 2 were and of cells were and in of 1 1 supplemented with and through a were at at The was in of supplemented with at 1 and at 1 in a The was as the In the the from was at in a and the is as the The was in 100 of and was as the IRS-1 and IRS-2 were from mouse from mouse were by and a of FLAG were mouse IRS-1 or IRS-2 SirT1 was obtained from and of were SirT1 of RNA interference from was used by the using a against SirT1 or against (11Zhang J. Biochem. J. 2006; 397: 519-527Crossref PubMed Scopus (110) Google Scholar). deletion were using the from by using the of the both of the using as of of were using the by mutant using as The mutant was used as a to mutant and the mutant was used as to and cells, cells were at 2 1 and were with various as in the HEK293 cells, these cells were set up at and with using were were with various as in the cells were and in 1 supplemented with and by up and were of at of cell were with protein A/G plus beads at and the were and with primary antibody by the of of protein A/G plus beads an 1 Protein A/G plus beads were at 1 using several with and to or cell were in supplemented with and at were using and to RNA was using from the of RNA was RNA by and to a The were with using a from Biosciences. was at in to the were to at either or Cell cells were with RNA against either or the SirT1 using were isolated by at The stable were isolated on using against HEK293 stable cells were with or using and stable were isolated using at 1 The stable were isolated on using SirT1 antibody from Santa In cells were with using to the cells were cell were using HEK293 cells were also and with insulin SirT1 protein was using rabbit antibody from cell and several in the 100 and The beads were deacetylation and 1 with and and 2 at were using a and in chemical including nicotinamide and have been demonstrated to potently inhibit protein deacetylase activity of SirT1 R.M. M. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar). These were used to cells to on insulin-induced MAPK and Insulin treatment demonstrated by phosphorylations at both threonine and 473 of protein. of either nicotinamide at or at 100 significantly inhibited insulin-induced phosphorylations at both However, the these had minimal on insulin-induced MAPK demonstrated by phosphorylations of kinase study of the nicotinamide effect on insulin-induced MAPK and was in were with nicotinamide ranging from to and showed that MAPK was by nicotinamide treatment at insulin-induced was inhibited with nicotinamide and significantly inhibited with the that these results were to cell were also using primary hepatocytes and cells In these cells nicotinamide significantly inhibited insulin-induced had minimal on insulin-induced MAPK The nicotinamide effect on the insulin regulation of downstream gene at the level was also investigated with was in SirT1 cells M.C. N. Lemieux M. C. D. W. Y. McBurney M. Guarente L. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar), nicotinamide treatment led to a significantly increased level of at the basal had effect on the effect of insulin on treatment also suppressed insulin-induced of The level of was as the control in this These results suggest that of SirT1 activity with insulin signaling pathway at both protein and SirT1 activity was also inhibited through SirT1 level by RNAi, and its effect on insulin signaling pathway was to any possible of chemical compound stable either RNA against or SirT1 were isolated through and insulin-induced MAPK and were in these cells. was in was isolated from cells with whereas 1 and 2 were from cells with In all insulin treatment led to MAPK kinase was also potently by insulin treatment in and as in showed that the SirT1 level was only reduced in in further supporting the that SirT1 activity was insulin-induced The level of was used as the the of the stable cells were SC cells, whereas 2 or any SirT1 was significantly reduced was SS cells. Insulin signaling pathway was further to the underlying mechanism of the effect of reduced SirT1 activity on insulin-induced critical step in insulin signaling pathway is the tyrosine phosphorylation of insulin receptor which further tyrosine residues in both IRS-1 and IRS-2. the tyrosine phosphorylation of IRS-1, and IRS-2 were between SC and SS cells upon insulin treatment Insulin treatment led to tyrosine phosphorylations of IRS-1, and IRS-2 in SC cells. However, in SS cells, whereas and IRS-1 to the tyrosine phosphorylation level of IRS-2 was significantly results were obtained using cells with nicotinamide The impaired tyrosine phosphorylation of IRS-2 protein in SS cells of insulin treatment These that SirT1 activity may insulin-induced IRS-2 tyrosine phosphorylation. further of the molecular mechanism underlying the regulatory effect of SirT1 on insulin-induced IRS-2 tyrosine and were from mouse and were used to with FLAG These were in HEK293 cells and The cells were with or of nicotinamide and with insulin with the in cells, insulin treatment led to tyrosine phosphorylations of both and However, nicotinamide had minimal effect on insulin-induced IRS-1 tyrosine phosphorylation it reduced insulin-induced tyrosine phosphorylation of IRS-2 protein significantly IRS-2 in HEK293 cells to nicotinamide treatment as IRS-2 protein. The of SirT1 deacetylase activity insulin-induced tyrosine phosphorylation of IRS-2 a that acetylation and tyrosine phosphorylation of IRS-2 and deacetylation of IRS-2 by SirT1 a insulin-induced tyrosine phosphorylation of IRS-2. to this is that SirT1 protein is as a protein, whereas IRS-2 protein is to a protein G. Kahn C.R. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar). The of SirT1 are all proteins M.C. N. Lemieux M. C. D. W. Y. McBurney M. Guarente L. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, F. M.W. J. 2004; PubMed Scopus Google Scholar, S. M.M. T. Science. 2004; PubMed Scopus Google Scholar, S. M.M. T. J. Biol. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar, S. A. A. C. P. McBurney M.W. H. M. E. M. PLoS Biol. 2005; PubMed Scopus Google Scholar, J. Imai S. D. F. A. Guarente L. W. Full Text Full Text PDF PubMed Scopus Google Scholar, H. E. Imai Guarente L. Full Text Full Text PDF PubMed Scopus Google Scholar, S. Proc. Natl. Acad. Sci. U. S. A. 2006; PubMed Scopus Google Scholar). of SirT1 was in HEK293 cells. Cell studies showed that SirT1 protein was in both and As two protein and element-binding protein, were mainly in whereas a protein, was mainly in the between IRS-2 and SirT1 proteins was using proteins in HEK293 cells. the mouse SirT1 with a was and with and IRS-2 of protein protein whereas of protein also protein This was using proteins in HEK293 cells. were and IRS-2 protein was using a polyclonal rabbit was used as using SirT1 antibody showed that IRS-2 protein interacted with SirT1 protein in The between IRS-1 and SirT1 was also in HEK293 cells using as demonstrated in IRS-1 interacted well with SirT1 as IRS-2. the acetylation of IRS-2 protein, IRS-2 protein was in HEK293 cells and with and of These cells were with insulin and using monoclonal mouse was used as showed that protein was acetylated at the basal level 1 with and treatment of insulin significantly reduced the acetylation level of 2 and of nicotinamide on the other hand, prevented insulin-induced deacetylation of IRS-2 protein with IRS-2 protein was from cells with and insulin treatment using polyclonal antibody normal rabbit as The acetylation of IRS-2 protein was and IRS-2 was acetylated at the basal level, and insulin treatment led to reduced acetylation level of IRS-2 protein. these results suggest that IRS-2 protein is acetylated at basal and its acetylation level is down-regulated by IRS-1 and IRS-2 interacted well with insulin-induced tyrosine phosphorylations of IRS-1 and IRS-2 to reduced SirT1 activity the acetylation of IRS-1 was also with that of IRS-2 in HEK293 cells using proteins with protein was acetylated at the basal level, and insulin treatment led to reduced acetylation level of the other hand, the protein of IRS-1 is that of IRS-2, the acetylation level of protein was to the showed that IRS-1 was and its acetylation was by insulin These results suggest that insulin-induced IRS-2 deacetylation is the regulatory effect of SirT1 on insulin-induced IRS-2 tyrosine phosphorylation. The direct of SirT1 in insulin-induced IRS-2 deacetylation was also investigated in an in deacetylation IRS-2 protein was in HEK293 cells and from cell using monoclonal SirT1 protein was also from HEK293 cells. The protein and SirT1 protein were set up as in 2 at and the acetylation level of protein was The of SirT1 protein had a minimal effect on the acetylation level of protein. However, the of SirT1 protein in the of significantly reduced acetylation level of to level the with This that IRS-2 protein may a substrate of SirT1 protein and SirT1 is insulin-induced IRS-2 deacetylation in The direct connection between IRS-2 acetylation and tyrosine phosphorylation was further demonstrated in stable from HEK293 cells with either or These cells were with as demonstrated in protein was using and normal mouse was used as the control in The acetylation and tyrosine phosphorylation of protein were in both with and insulin treatment. with cells with normal SirT1 the basal acetylation level of was and insulin-induced deacetylation of was inhibited in cells with reduced SirT1 protein and with its reduced tyrosine phosphorylation level and The between IRS-2 acetylation and tyrosine phosphorylation that or acetylated lysine residues in IRS-2 protein may critical SirT1 regulation of insulin-induced tyrosine phosphorylation of IRS-2. However, to these acetylation in IRS-2 protein may there is a of lysine residues in the IRS-2 the other hand, the that nicotinamide significantly prevented insulin-induced deacetylation and tyrosine phosphorylation of IRS-2 protein it is to that insulin-induced tyrosine phosphorylations of IRS-2 acetylated lysine residues suppressed by a of deletion of were to IRS-2 these lysine this the acetylation residues of IRS-2 was to the of IRS-2 protein. IRS-1 and IRS-2 at the Y. L. E. Nature. PubMed Scopus Google Scholar), with IRS-2, IRS-1 is and its acetylation was by insulin These observations suggest that the acetylation residues critical to insulin-induced tyrosine phosphorylation of IRS-2 may to IRS-2 protein. IRS-1 and IRS-2 was using the of the of there were only four lysine residues in the IRS-2 and These four lysine residues are also conserved in IRS-2 of were to these four lysine residues to and the mutant is The acetylation and tyrosine phosphorylation of this mutant in to insulin treatment was with of in with the the basal acetylation level of this mutant was significantly reduced with that of the protein with its tyrosine phosphorylation level upon insulin treatment. These results further support that insulin-induced deacetylation of IRS-2 by SirT1 is a critical step insulin-induced IRS-2 tyrosine phosphorylation. In this study reduced SirT1 deacetylase either through direct or through reduced protein led to reduced and insulin-induced IRS-2 tyrosine IRS-2 was acetylated at basal and the acetylation of IRS-2 was down-regulated by of SirT1 activity prevented insulin-induced IRS-2 an IRS-2 mutant was four lysine residues were to and the basal level acetylation of this mutant protein was significantly inhibited with its tyrosine phosphorylation upon insulin treatment. on these the underlying molecular mechanism of the regulatory effect of SirT1 on the insulin signaling pathway is in In this model insulin-induced tyrosine phosphorylation of insulin receptor and of SirT1 deacetylase are to two in insulin signaling IRS-2 protein is acetylated at the basal insulin treatment leads to tyrosine phosphorylation of which further insulin receptor including IRS-1 and IRS-2 to its kinase the acetylated lysine residues in IRS-2 protein kinase from further tyrosine residues in IRS-2 protein. phosphorylation of the tyrosine residues in IRS-2 protein of the from acetylated lysine residues in IRS-2 protein by SirT1 protein and the phosphorylated IRS-2 protein as an adaptor protein to further transmit insulin signaling to downstream there are in this and further are to or this In this model is on cell culture studies are to this model and to its physiological deacetylation of IRS-2 protein its tyrosine phosphorylation is a with protein has been in a study S. J.D. Biochem. J. PubMed Scopus Google Scholar). of deacetylation of acetylated lysine is to its These of lysine residues deacetylation may critical role in insulin-induced tyrosine phosphorylation of IRS-2 protein, as of these either through acetylation or to alanine all with reduced tyrosine phosphorylation of IRS-2 protein. of lysine to this protein which is with the observations that insulin treatment leads to IRS-2 tyrosine phosphorylation and in L. J. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar, D. S. Kahn C.R. J. PubMed Scopus Google Scholar). the of this regulation on overall energy homeostasis is the physiological of this regulation has been in several The SirT1 protein level has been at a reduced level in mice to PubMed Scopus Google Scholar) and in two aging M. N. S. E. D. Cell 2006; PubMed Scopus Google Scholar). aging and are known to associated with insulin in SirT1 these through with the insulin signaling pathway may or at significantly to overall insulin in the insulin signaling pathway and Sir2 family deacetylases have been associated with and there is evidence that these two pathways may to regulate aging process in C. of the C. elegans of Sir2, significantly lifespan in C. elegans, and this effect is suppressed by at the C. elegans homologue of and a key component of insulin signaling pathway Guarente L. Nature. PubMed Scopus Google Scholar). In a mammalian system, SirT1 is to insulin secretion in (4Bordone L. Motta M.C. Picard F. Robinson A. Jhala U.S. Apfeld J. McDonagh T. Lemieux M. McBurney M. Szilvasi A. Easlon E.J. Lin S.J. Guarente L. PLoS Biol. 2006; 4: e31Crossref PubMed Scopus (625) Google Scholar, 5Moynihan K.A. Grimm A.A. Plueger M.M. Bernal-Mizrachi E. Ford E. Cras-Meneur C. Permutt M.A. Imai S. Cell Metab. 2005; 2: 105-117Abstract Full Text Full Text PDF PubMed Scopus (546) Google Scholar), and it also the activity of proteins at the level M.C. N. Lemieux M. C. D. W. Y. McBurney M. Guarente L. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar, A. Lin Y. H. Gygi S.P. Science. 2004; PubMed Scopus Google Scholar). This study well with these a pathway through which both the insulin signaling pathway and Sir2 family deacetylases on to regulate the aging process. components of the insulin signaling pathway have been demonstrated to involved in the aging process ranging from C. elegans to mammals, the role of IRS proteins in this process is is the role of elegans homologue of IRS in the aging process G. J. Biol. Full Text Full Text PDF PubMed Scopus Google Scholar). the other hand, of the homologue of IRS leads to significant lifespan extension D. S. H. E. S.J. L. Science. PubMed Scopus Google Scholar). In the mammalian system, there is a family of four IRS proteins with The effect of SirT1 on IRS-2 tyrosine phosphorylation that IRS-2 other of IRS family proteins may critical role in the aging process. This study also further the molecular mechanism underlying the regulatory effect of SirT1 protein deacetylase on aging and other metabolic The regulatory effect of Sir2 family protein deacetylases in the aging process has been well in C. elegans, yeast, and (2Blander G. Guarente L. Annu. Rev. Biochem. 2004; 73: 417-435Crossref PubMed Scopus (1313) Google Scholar). However, the molecular mechanism underlying this regulation is The identification of IRS-2 as substrate of SirT1 that SirT1 may also through regulating signaling pathway to control aging and other In with SirT1 and IRS-2 support this H. S. Y. D. S. S. Nature. PubMed Scopus Google Scholar, M.W. M. Lemieux M. Biol. 2003; PubMed Scopus Google Scholar). The mice of both IRS-2 and SirT1 showed with and reduced and M.W. M. Lemieux M. Biol. 2003; PubMed Scopus Google Scholar, J. M. Nature. PubMed Scopus Google Scholar). The in between SirT1 and IRS-2 mice imply an connection between SirT1 and signaling pathway in in this study is the of SirT1 protein. SirT1 protein has been demonstrated as a protein A. M. D. H. P. D. 2004; Full Text Full Text PDF PubMed Scopus Google Scholar). However, this study on this demonstrate the of SirT1 protein in it the of this protein in the of SirT1 protein in was also in several other studies, including the phosphatidylinositol regulation of of SirT1 protein M. J. T. Y. J. Biol. 2006; Full Text Full Text PDF PubMed Scopus Google Scholar) and the SirT1 deacetylation of a known protein S. Proc. Natl. Acad. Sci. U. S. A. 2006; PubMed Scopus Google Scholar). In this study also the signaling pathway to the of MAPK and MAPK and kinase are important components of insulin signaling pathway, a of downstream In this study reduced IRS-2 tyrosine phosphorylation in cells with impaired SirT1 activity led to significantly reduced had minimal effect on MAPK that IRS-2 tyrosine phosphorylation may with in these cells. This is with a study mouse from and IRS-2 mice were with that of insulin-induced was significantly in IRS-2 whereas insulin-induced MAPK was I. H. H. C. S.J. I. M. M. S. I. Biol. PubMed Scopus Google Scholar). However, in other studies, reduced IRS-2 protein through led to on and MAPK including increased in mouse Kahn J. 2005; PubMed Scopus Google Scholar) or reduced of both MAPK and in cells A. L. B.B. A. Cell Metab. 2006; 4: Full Text Full Text PDF PubMed Scopus Google Scholar, S. Lin J. 2006; PubMed Scopus Google Scholar). The molecular mechanism underlying these is The may tissue and that that in this study the overall tyrosine phosphorylation level the protein level of IRS-2 protein was significantly In the study that SirT1 protein through regulation of the acetylation level of IRS-2 protein, regulate insulin-induced IRS-2 tyrosine phosphorylation and its downstream This study also that deacetylation of IRS-2 protein is a critical component of insulin-induced IRS-2 tyrosine phosphorylation. The identification of a novel regulatory step in insulin-induced IRS-2 tyrosine phosphorylation and the novel role of SirT1 in regulation of insulin signaling pathway also have direct in understanding of and other metabolic processes associated with insulin signaling of support and of support and with

References

37